Covestor’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $360K | Buy |
39,473
+19,694
| +100% | +$180K | 0.21% | 56 |
|
2025
Q1 | $157K | Buy |
19,779
+19,772
| +282,457% | +$157K | 0.1% | 236 |
|
2024
Q4 | $0 | Buy |
7
+1
| +17% | – | ﹤0.01% | 2675 |
|
2024
Q3 | $0 | Sell |
6
-1
| -14% | – | ﹤0.01% | 2689 |
|
2024
Q2 | $0 | Buy |
7
+4
| +133% | – | ﹤0.01% | 2688 |
|
2024
Q1 | $0 | Sell |
3
-1
| -25% | – | ﹤0.01% | 2680 |
|
2023
Q4 | $0 | Sell |
4
-46
| -92% | – | ﹤0.01% | 2662 |
|
2023
Q3 | $1K | Buy |
50
+45
| +900% | +$900 | ﹤0.01% | 1986 |
|
2023
Q2 | $0 | Sell |
5
-280
| -98% | – | ﹤0.01% | 2595 |
|
2023
Q1 | $12K | Buy |
285
+3
| +1% | +$126 | 0.01% | 1232 |
|
2022
Q4 | $11K | Buy |
282
+275
| +3,929% | +$10.7K | 0.01% | 1294 |
|
2022
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 2507 |
|
2022
Q2 | $0 | Sell |
7
-97
| -93% | – | ﹤0.01% | 2301 |
|
2022
Q1 | $3K | Sell |
104
-4
| -4% | -$115 | ﹤0.01% | 1613 |
|
2021
Q4 | $5K | Buy |
+108
| New | +$5K | 0.01% | 1336 |
|